|
112P Patient-reported outcomes (PROs) with first-line (1L) cemiplimab in patients with locally advanced non-small cell lung cancer (laNSCLC): EMPOWER-Lung 1 subpopulation |
|
|
|
Titel: |
112P Patient-reported outcomes (PROs) with first-line (1L) cemiplimab in patients with locally advanced non-small cell lung cancer (laNSCLC): EMPOWER-Lung 1 subpopulation |
Auteur: |
Bondarenko, I. Sezer, A. Kilickap, S. Gümüş, M. Özgüroğlu, M. Gogishvili, M. He, X. Gullo, G. Rietschel, P. Quek, R.G. |
Verschenen in: |
Annals of oncology |
Paginering: |
Jaargang 33 () nr. S2 pagina's S84-S85 |
Jaar: |
2022 |
Inhoud: |
|
Uitgever: |
European Society for Medical Oncology |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|